CATALYST PHARMACEU earnings per share and revenue

CN2 earnings per share for the last quarter are 0.30 CHF whereas the estimation was 0.26 CHF which accounts for 15.13% surprise. Company revenue for the same period amounts to 107.14 M CHF despite the estimated figure of 104.58 M CHF. Estimated earnings per share for the next quarter are 0.30 CHF, and revenue is expected to reach 118.60 M CHF. Also watch annual changes over time to get a bigger picture of CN2 earnings per share and revenue dynamics.